1. bookVolume 61 (2011): Edizione 4 (December 2011)
Dettagli della rivista
License
Formato
Rivista
eISSN
1846-9558
ISSN
1330-0075
Prima pubblicazione
28 Feb 2007
Frequenza di pubblicazione
4 volte all'anno
Lingue
Inglese
Accesso libero

Synthesis, in vitro anticancer screening and radiosensitizing evaluation of some new 4-[3-(substituted)thioureido]-N-(quinoxalin-2-yl)-benzenesulfonamide derivatives

Pubblicato online: 25 Dec 2011
Volume & Edizione: Volume 61 (2011) - Edizione 4 (December 2011)
Pagine: 415 - 425
Dettagli della rivista
License
Formato
Rivista
eISSN
1846-9558
ISSN
1330-0075
Prima pubblicazione
28 Feb 2007
Frequenza di pubblicazione
4 volte all'anno
Lingue
Inglese

V. K. Tandon, D. B. Yadav, H. K. Maurya, A. K. Chaturvedi and P. K. Shukla, Design, synthesis, and biological evaluation of 1,2,3-trisubstituted-1,4-dihydrobenzo[g]quinoxaline-5,10-diones and related compounds as antifungal and antibacterial agents, Bioorg. Med. Chem. 14 (2006) 6120-6126; DOI: 10.1016/j.bmc.2006.04.029.10.1016/j.bmc.2006.04.029Search in Google Scholar

S. Sehlstedt, P. Aich, J. Bergman, H. Vallberg, B. Nordén and A. Gräslund, Interactions of the antiviral quinoxaline derivative 9-OH-B220 {2,3-dimethyl-6-(dimethylaminoethyl)-9-hydroxy-6H-indolo-[2,3-b]quinoxaline} with duplex and triplex forms of synthetic DNA and RNA, J. Mol. Biol. 278 (1998) 31-56; DOI: 10.1006/jmbi.1998.1670.10.1006/jmbi.1998.1670Search in Google Scholar

A. Carta, M. Loriga, G. Paglietti, A. Mattana, P. L. Fiori, P. Mollicotti, L. Mollicotti and S. Zanetti, Synthesis, anti-mycobacterial, anti-trichomonas and anti-candida in vitro activities of 2-substituted-6,7-difluoro-3-methylquinoxaline 1,4-dioxides, Eur. J. Med. Chem. 39 (2004) 195-203; DOI: 10.1016/j.ejmech.2003.11.008.10.1016/j.ejmech.2003.11.008Search in Google Scholar

M. H. Fisher, A. Lusi and J. R. Egerton, Anthelmintic dihydroquinoxalino[2,3-b]quinoxalines, Eur. J. Med. Chem. 66 (1997) 1349-1352; DOI: 10.1002/jps.2600660942.10.1002/jps.2600660942Search in Google Scholar

A. Budakoti, A. R. Bhat and A. Azam, Synthesis of new 2-(5-substituted-3-phenyl-2-pyrazolinyl)-1,3-thiazolino[5,4-b]quinoxaline derivatives and evaluation of their antiamoebic activity, Eur. J. Med. Chem. 44 (2009) 1317-1325; DOI: 10.1016/j.ejmech.2008.02.002.10.1016/j.ejmech.2008.02.002Search in Google Scholar

R. S. Giri, H. M. Thaker, T. Giordano, J. Williams, D. Rogers, V. Sudersanam and K. K. Vasu, Design, synthesis and characterization of novel 2-(2,4-disubstituted-thiazole-5-yl)-3-aryl-3H-quinazoline-4-one derivatives as inhibitors of NF-κB and AP-1 mediated transcription activation and as potential anti-inflammatory agents, Eur. J. Med. Chem. 44 (2009) 2184-2189; DOI: 10.1016/j.ejmech.2008.10.031.10.1016/j.ejmech.2008.10.031Search in Google Scholar

J. S. Fisherman, B. L. Osborn and H. G. Chun, Chloroquinoxaline sulfonamide: A sulfanilamide antitumor agent entering clinical trials, Invest. New Drugs. 11 (1993) 1-9; DOI: 10.1007/BF00873904.10.1007/BF00873904Search in Google Scholar

F. Mohamadi, M. M. Spees and G. B. Grindey, Sulfonylureas: A new class of cancer chemotherapeutic agents, J. Med. Chem. 35 (1992) 3012-3016; DOI: 10.1021/jm00094a013.10.1021/jm00094a013Search in Google Scholar

G. F. Rush, S. Rinzel, G. Boder, R. A. Heim, J. E. Toth and G. D. Ponsler, Effects of diarylsulfonylurea antitumor agents on the function of mitochondria isolated from rat liver and GC3/c1 cells, Biochem. Pharmacol. 44 (1992) 2387-2394; DOI: 10.1016/0006-2952(92)90684-B.10.1016/0006-2952(92)90684-BSearch in Google Scholar

M. M. Ghorab, F. A. Ragab, H. I. Heiba, R. K. Arafa and E. M. El-Hossary, In vitro anticancer screening and radiosensitizing evaluation of some new quinolines and pyrimido[4,5-b]quinolines bearing a sulfonamide moiety, Eur. J. Med. Chem. 459 (2010) 3677-3684; DOI: 10.1016/j.ejmech.2010.05.014.10.1016/j.ejmech.2010.05.01420684857Search in Google Scholar

M. M. Ghorab, F. A. Ragab and M. M. Hamed, Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety, Eur. J. Med. Chem. 44 (2009) 4211-4217; DOI: 10.1016/j.ejmech.2009.05.017.10.1016/j.ejmech.2009.05.01719540022Search in Google Scholar

M. M. Ghorab, F. A. Ragab, S. I. Alquasoumi, A. M. Alafeefy and S. A. Aboulmagd, Synthesis of some new pyrazolo[3,4-d]pyrimidine derivatives of expected anticancer and radioprotective activity, Eur. J. Med. Chem. 45 (2010) 171-178; DOI: 10.1016/j.ejmech.2009.09.039.10.1016/j.ejmech.2009.09.03919853327Search in Google Scholar

P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenny and M. R. Boyd, New colorimetric cytotoxicity assay for anticancer-drug screening, J. Natl. Cancer Inst. 82 (1990) 1107-1112; DOI: 10.1093/jnci/82.13.1107.10.1093/jnci/82.13.11072359136Search in Google Scholar

M. S. A. El-Gaby, A. M. Hussein, F. A. M. Abu-Shanab and M. A. M. Abdel Raheim, some hitherto unknown thiosemicarbazide, thiourea, bisthiourea, benzoazole derivatives bearing quinoxalin-2-yl moiety and evaluate their biological activity, Afinidad 60 (2003) 358-369; DOI: 2780.35400011978567.0050.Search in Google Scholar

Y. Nishimura, Rationale for chemoradiotherapy, Int. J. Clin. Oncol. 9 (2004) 414-420; DOI: 10.1007/s10147-004-0443-z.10.1007/s10147-004-0443-z15616871Search in Google Scholar

Articoli consigliati da Trend MD

Pianifica la tua conferenza remota con Sciendo